# SigTuple Technologies Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sigtuple-technologies-private

- Industry: Healthcare IT
- Headquarters: Bangalore, India
- Website: www.sigtuple.com
- Total disclosed funding: $47M
- Latest round: Series C (Aug 6, 2024)
- Investors on record: 10

## About

SigTuple Technologies Private Limited, based in India, develops AI-driven diagnostic solutions, enhancing the accuracy and efficiency of medical diagnostics in healthcare facilities, with core offerings such as automated analyzers and smart microscopes.Founded in 2015, SigTuple Technologies Private Limited operates from Bangalore, India, specializing in intelligent screening solutions for diagnostic processes. Tathagato Dastidar serves as both the founder and CEO. The company has achieved a total of 10 deals so far, with the latest funding round being a Series C, raising USD 4.00 mn on August 6, 2024, led by SIDBI Venture Capital and supported by Endiya. This funding marks the total amount raised to USD 4.00 mn since inception.SigTuple specializes in developing intelligent screening solutions that enhance diagnostic processes through AI-powered analysis of visual medical data. Their key products include Shonit, an automated peripheral blood smear slide analyzer; AI100, a smart robotic microscope; and Shrava, an automated urine sediment analyzer. These innovations streamline workflows in pathology and laboratory settings, primarily serving clients in the United States and India, thus addressing the growing demand for efficient diagnostic tools in these regions.In 2022, SigTuple reported revenue of USD 44,304.90 from its advanced diagnostic tools, which are sold directly to healthcare providers and laboratories. The company’s revenue model includes hardware sales and ongoing service agreements, supporting the functionality of equipment like Shonit, AI100, and Shrava.In August 2024, SigTuple Technologies Private Limited raised USD 4.00 mn in Series C funding, which will be utilized to expand their product portfolio and geographical reach, as well as to facilitate regulatory clearances. The company aims to introduce new products and target new markets, although specific product launch dates or regions have not been disclosed.

## Funding rounds

- Series C, Aug 6, 2024, $4M — SIDBI Venture Capital, Endiya
- Series C, Mar 3, 2023, $3.4M — Accel, Endiya
- Series C, Jan 24, 2023, $1M — Accel
- Series C, Dec 17, 2021, $1.4M — Accel, Endiya, Axilor Ventures
- Series C, May 17, 2019, $16M — Accel, Chiratae Ventures, Trifecta Capital, Trusted Insight, pi Ventures
- Series B, Jul 23, 2018, $15M — Accel, Chiratae Ventures, Trifecta Capital, Endiya, Axilor Ventures, pi Ventures, VH Capital, General Catalyst India
- Series A, Mar 13, 2017, $5.4M — Accel, Chiratae Ventures, Endiya, Axilor Ventures, pi Ventures, VH Capital
- Series A, Feb 9, 2017, $0.5M — Accel
- Seed, Feb 22, 2016 — Accel

## Investors

- Accel (https://capitalatlas.ai/funds/accel) — Seed, Series A, Series B, Series C
- Chiratae Ventures (https://capitalatlas.ai/funds/chiratae-ventures) — Series A, Series B, Series C
- Endiya (https://capitalatlas.ai/funds/endiya) — Series A, Series B, Series C
- Axilor Ventures (https://capitalatlas.ai/funds/axilor-ventures) — Series A, Series B, Series C
- pi Ventures (https://capitalatlas.ai/funds/pi-ventures) — Series A, Series B, Series C
- VH Capital — Series A, Series B
- Trifecta Capital (https://capitalatlas.ai/funds/trifecta-capital) — Series B, Series C
- General Catalyst India (https://capitalatlas.ai/funds/general-catalyst-india) — Series B
- Trusted Insight — Series C
- SIDBI Venture Capital (https://capitalatlas.ai/funds/sidbi-venture-capital) — Series C